Combined cytotoxic and endocrine therapy in postmenopausal patients with advanced breast cancer. A randomized study of CMF vs CMF plus tamoxifen
- 1 March 1985
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 21 (3) , 291-299
- https://doi.org/10.1016/0277-5379(85)90128-2
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Treatment of Advanced Breast Cancer with TamoxifenPublished by Springer Nature ,1984
- Chemotherapy versus combination of chemotherapy and endocrine therapy in advanced breast cancer: A prospective randomized studyCancer, 1983
- Concurrent or sequential use of cytotoxic chemotherapy and hormone treatment in advanced breast cancer: report of the Swiss Group for Clinical Cancer Research.BMJ, 1983
- Treatment of metastatic breast cancer in estrogen receptor positive patients a randomized trial comparing tamoxifen alone versus tamoxifen plus CMFCancer, 1982
- Dibromodulcitol and Adriamycin ± tamoxifen in advanced breast cancer*American Journal of Clinical Oncology, 1982
- Tamoxifen in advanced breast cancerCancer Treatment Reviews, 1978
- Assessment of response to therapy in advanced breast cancer.A project of the programme on clinical oncology of the International Union against Cancer, Geneva, SwitzerlandCancer, 1977
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Integration of chemotherapy into combined modality treatment of solid tumors: VII. Adenocarcinoma of the breastCancer Treatment Reviews, 1976
- CONFIDENCE LIMITS IN EVALUATING CONTROLLED THERAPEUTIC TRIALSThe Lancet, 1973